Table 1.

Pediatric patients transplanted for hepatoblastoma at our center before (Era 1) and after (Era 2) implementation of pediatric end-stage liver disease exception points for hepatoblastoma

	Era 1 (1987-2009)	Era 2 (2010-2014)	Significance (P-value)
Total patients listed for transplantation	7	14	0.189
Gender			0.557
Male	57.10%	35.70%
Female	42.90%	64.30%
Age at listing (yr)	5.4	2	0.094
Age at transplant (yr)	5.6	2.1	0.110
Waitlist time (d)	45.6	25.4	0.025